galantamine and soman
galantamine has been researched along with soman in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Agnusdei, M; Belinskaya, T; Borriello, M; Brindisi, M; Butini, S; Campiani, G; Catalanotti, B; Fattorusso, C; Fiorini, I; Gemma, S; Nacci, V; Novellino, E; Panico, A; Persico, M; Ros, S; Saxena, A | 1 |
Adler, M; Albuquerque, EX; Aracava, Y; Fawcett, WP; Hamilton, TA; Kan, RK; Oliveira, M; Pereira, EF; Randall, WR; Romano, JA | 1 |
Kellar, KJ | 1 |
Albuquerque, EX; Alkondon, M; Aracava, Y; Pereira, EF | 1 |
Akkerman, M; Albuquerque, EX; Alkondon, M; Aracava, Y; Merchenthaler, I; Pereira, EF | 1 |
Adler, M; Akkerman, M; Albuquerque, EX; Aracava, Y; Pereira, EF | 1 |
Albuquerque, EX; Aracava, Y; Gullapalli, RP; Helal Neto, E; Makris, G; Merchenthaler, I; Pereira, EF; Wang, J; Zhuo, J | 1 |
Albuquerque, EX; Alexandrova, EA; Aracava, Y; Pereira, EF | 1 |
Albuquerque, EX; Kulkarni, GS; Mamczarz, J; Pereira, EF | 1 |
Albuquerque, EX; Alexandrova, EA; Alkondon, M; Aracava, Y; Pereira, EF | 1 |
Acharya, J; Dubey, DK; Golime, R; Palit, M | 1 |
Other Studies
11 other study(ies) available for galantamine and soman
Article | Year |
---|---|
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Computational Biology; Crystallography, X-Ray; Drug Design; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Tacrine | 2008 |
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Topics: Acetylcholinesterase; Alkaloids; Animals; Atropine; Behavior, Animal; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Lethal Dose 50; Neurons; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Poisoning; Pyridostigmine Bromide; Sarin; Sesquiterpenes; Soman; Time Factors | 2006 |
Overcoming inhibitions.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Atropine; Benzodiazepines; Blood-Brain Barrier; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Neurons; Neurotransmitter Agents; Organophosphate Poisoning; Organophosphates; Organophosphorus Compounds; Paraoxon; Pralidoxime Compounds; Pyridostigmine Bromide; Receptors, Cholinergic; Receptors, Muscarinic; Sarin; Seizures; Soman; Time Factors | 2006 |
A single in vivo application of cholinesterase inhibitors has neuron type-specific effects on nicotinic receptor activity in guinea pig hippocampus.
Topics: Animals; Cholinesterase Inhibitors; Galantamine; Guinea Pigs; Hippocampus; In Vitro Techniques; Interneurons; Male; Neurons; Patch-Clamp Techniques; Pyramidal Cells; Receptors, Nicotinic; Soman; Survival Analysis | 2009 |
Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chemical Warfare Agents; Cholinergic Fibers; Cholinesterase Inhibitors; Cholinesterase Reactivators; Drug Interactions; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Male; Muscarinic Antagonists; Nerve Degeneration; Organ Culture Techniques; Organophosphate Poisoning; Organophosphorus Compounds; Sarin; Soman; Treatment Outcome | 2010 |
Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.
Topics: Acetylcholinesterase; Alkaloids; Animals; Antidotes; Chemical Warfare Agents; Donepezil; Dose-Response Relationship, Drug; Galantamine; Guinea Pigs; Indans; Lethal Dose 50; Male; Phenylcarbamates; Piperidines; Poisoning; Rivastigmine; Sesquiterpenes; Soman; Time Factors; Toxicity Tests, Acute | 2009 |
Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.
Topics: Animals; Brain; Brain Mapping; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Galantamine; Gene Expression Regulation; Guinea Pigs; Magnetic Resonance Imaging; Neurogranin; Neurotoxicity Syndromes; Nootropic Agents; RNA, Messenger; Soman; Time Factors | 2010 |
Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus.
Topics: Animals; Antidotes; Cholinesterase Inhibitors; Data Interpretation, Statistical; Electrophysiology; Excitatory Postsynaptic Potentials; Female; Galantamine; gamma-Aminobutyric Acid; Guinea Pigs; Hippocampus; In Vitro Techniques; Lethal Dose 50; Patch-Clamp Techniques; Pyramidal Cells; Soman; Synaptic Transmission | 2010 |
Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance.
Topics: Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Extinction, Psychological; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Maze Learning; Motor Activity; Neuroprotective Agents; Nootropic Agents; Reaction Time; Soman; Time Factors | 2011 |
Galantamine prevents long-lasting suppression of excitatory synaptic transmission in CA1 pyramidal neurons of soman-challenged guinea pigs.
Topics: Animals; Behavior, Animal; CA1 Region, Hippocampal; Cholinesterase Inhibitors; Excitatory Postsynaptic Potentials; Female; Galantamine; Guinea Pigs; Pyramidal Cells; Soman | 2014 |
Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Brain-Derived Neurotrophic Factor; Galantamine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Muscarinic Antagonists; Nerve Agents; Neuroglia; Neuroprotective Agents; Protein Carbonylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger; S100 Calcium Binding Protein beta Subunit; Soman; Time Factors | 2018 |